Jong-Seok Lee

400 total citations
18 papers, 341 citations indexed

About

Jong-Seok Lee is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Jong-Seok Lee has authored 18 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Cancer Research. Recurrent topics in Jong-Seok Lee's work include Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Ginseng Biological Effects and Applications (2 papers). Jong-Seok Lee is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Ginseng Biological Effects and Applications (2 papers). Jong-Seok Lee collaborates with scholars based in South Korea, United States and Japan. Jong-Seok Lee's co-authors include Pyeongjae Lee, Hocheol Kim, Sun Yeou Kim, Hideo Yagita, Sunshin Kim, Myung‐Shik Lee, Kyoungho Suk, Chang‐Ju Kim, Sylvain Doré and Emanuela Tolosano and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Brain Research.

In The Last Decade

Jong-Seok Lee

16 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jong-Seok Lee South Korea 8 128 115 61 53 49 18 341
Xiaoqin Zhu China 12 146 1.1× 132 1.1× 39 0.6× 59 1.1× 32 0.7× 22 371
Arjun Sapkota South Korea 13 270 2.1× 197 1.7× 55 0.9× 83 1.6× 64 1.3× 17 520
Ik-Hyun Cho South Korea 8 180 1.4× 137 1.2× 42 0.7× 131 2.5× 53 1.1× 12 473
Manabu Takemura Japan 12 168 1.3× 65 0.6× 26 0.4× 37 0.7× 65 1.3× 22 476
Fereshteh Pourabdolhossein Iran 14 157 1.2× 69 0.6× 48 0.8× 30 0.6× 44 0.9× 25 394
Yijia Zong United States 7 154 1.2× 112 1.0× 18 0.3× 61 1.2× 61 1.2× 8 376
Mónica Espinoza-Rojo Mexico 12 224 1.8× 93 0.8× 20 0.3× 40 0.8× 64 1.3× 25 523
Denglei Ma China 13 128 1.0× 82 0.7× 29 0.5× 19 0.4× 106 2.2× 23 335
Ye Peng China 8 153 1.2× 68 0.6× 32 0.5× 24 0.5× 51 1.0× 15 331

Countries citing papers authored by Jong-Seok Lee

Since Specialization
Citations

This map shows the geographic impact of Jong-Seok Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong-Seok Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong-Seok Lee more than expected).

Fields of papers citing papers by Jong-Seok Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong-Seok Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong-Seok Lee. The network helps show where Jong-Seok Lee may publish in the future.

Co-authorship network of co-authors of Jong-Seok Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jong-Seok Lee. A scholar is included among the top collaborators of Jong-Seok Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong-Seok Lee. Jong-Seok Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Girard, Nicolas, Martin Wermke, Fabrice Barlési, et al.. (2021). Phase Ib study of BI 836880 (VEGF/Ang2 nanobody) plus ezabenlimab (BI 754091; anti-PD-1 antibody) in patients (pts) with solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 2579–2579. 4 indexed citations
3.
Park, Keunchil, Jong-Seok Lee, Sang‐We Kim, et al.. (2018). BIW-8962, an Anti GM2 Ganglioside Monoclonal Antibody, in Previously Treated Advanced/Recurrent Lung Cancer: a Phase I/II Study. 4(1). 101–201. 1 indexed citations
4.
Choi, Jia, Jong-Seok Lee, Hyeon‐Son Choi, et al.. (2018). Compound K Inhibits the Lipopolysaccharide-Induced Inflammatory Responses in Raw 264.7 Cell Line and Zebrafish. Applied Sciences. 8(6). 924–924. 8 indexed citations
5.
Kim, Hyeong-Geug, Jongmin Han, Jin‐Seok Lee, et al.. (2014). Anti-melanoma activity of Cynanchi atrati Radix is mediated by regulation of NF-kappa B activity and pro-apoptotic proteins. Journal of Ethnopharmacology. 153(1). 250–257. 10 indexed citations
6.
Kim, Younghyun, Jong-Seok Lee, Hee‐Do Hong, et al.. (2013). Protective Effect of Ferments of Hot-water Extract Mixture from Rhodiola sachalinensis and Red Ginseng on Oxidative Stress-induced C2C12 Myoblast. The Korean Journal of Food And Nutrition. 26(3). 485–491. 1 indexed citations
7.
Lee, Jinseok, et al.. (2013). Myelophil attenuates brain oxidative damage by modulating the hypothalamus-pituitary-adrenal (HPA) axis in a chronic cold-stress mouse model. Journal of Ethnopharmacology. 148(2). 505–514. 27 indexed citations
8.
Lee, Hyi‐Seung, Hye‐Kyeong Kim, Yeon‐Ju Lee, et al.. (2012). Identification of New Polyprenyl Hydroquinone Derivatives from Tropical Marine Sponge lrcinia Ircinia sp.. Heterocycles. 85(6). 1437–1437. 5 indexed citations
9.
Lee, Hyi-Seung, Yeon‐Ju Lee, Chang‐Kwon Kim, et al.. (2012). Halenaquinone Derivatives from Tropical Marine Sponge Xestospongia sp.. Heterocycles. 85(4). 895–895. 7 indexed citations
10.
Lee, Jong-Seok, Tae Dong Kang, Boknam Chae, & Jae‐Young Kim. (2012). Synchrotron Infrared Spectroscopy. 21(10). 30–30. 1 indexed citations
11.
Saleem, Sofiyan, Gehua Zhen, Wangsen Cao, et al.. (2009). Heme–Hemopexin Complex Attenuates Neuronal Cell Death and Stroke Damage. Journal of Cerebral Blood Flow & Metabolism. 29(5). 953–964. 81 indexed citations
12.
Kim, Hyeong-Dong, et al.. (2006). A Case of Irritant Dermatitis due to Ranunculus japonicus. Linchuang pifuke zazhi. 44(8). 988–990. 1 indexed citations
13.
Kim, Young‐Ju, Susan Guo, Kwang‐Sung Ahn, et al.. (2005). Novel Synthetic Histone Deacetylase Inhibitor (SK-7041) Potently Inhibits Proliferation in Acute Myeloid Leukemia Cell Lines.. Blood. 106(11). 4407–4407. 2 indexed citations
14.
Lee, Jong-Seok, Dong-Wook Son, Pyeongjae Lee, et al.. (2003). Alkaloid fraction of Uncaria rhynchophylla protects against N-methyl-d-aspartate-induced apoptosis in rat hippocampal slices. Neuroscience Letters. 348(1). 51–55. 32 indexed citations
15.
Lee, Myoung-Hwa, Hong Kim, Baek-Vin Lim, et al.. (2003). Naloxone potentiates treadmill running-induced increase in c-Fos expression in rat hippocampus. Life Sciences. 73(24). 3139–3147. 17 indexed citations
16.
Lee, Jong-Seok, Pyeongjae Lee, Min-Chul Shin, et al.. (2003). Protective Effect of Methanol Extract of Uncaria rhynchophylla Against Excitotoxicity Induced by N-Methyl-D-Aspartate in Rat Hippocampus. Journal of Pharmacological Sciences. 92(1). 70–73. 34 indexed citations
17.
Lee, Pyeongjae, Jong-Seok Lee, Sunshin Kim, et al.. (2001). NO as an autocrine mediator in the apoptosis of activated microglial cells: correlation between activation and apoptosis of microglial cells. Brain Research. 892(2). 380–385. 105 indexed citations
18.
Bates, Susan E., Zhiqing Zhan, Bruce Dickstein, et al.. (1994). Reversal of multidrug resistance.. PubMed. 389. 33–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026